SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000891092-17-001361
Filing Date
2017-02-14
Accepted
2017-02-14 17:00:51
Documents
2
Group Members
JEREMY MINDICHMATTHEW SIROVICHSCOPIA MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A e73028_13ga.htm SC 13G/A 92953
2 AGREEMENT e73028ex99-1.htm EX-99.1 5205
  Complete submission text file 0000891092-17-001361.txt   100149
Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

IRS No.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address RUHRBERG SCIENCE BUILDING 3 PEKERIS ST. REHOVOT L3 7670203
Business Address RUHRBERG SCIENCE BUILDING 3 PEKERIS ST. REHOVOT L3 7670203 97289462729
NeuroDerm Ltd. (Subject) CIK: 0001598696 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-88692 | Film No.: 17610024
SIC: 2834 Pharmaceutical Preparations